Vinge Logotype
SvenskaEnglish 18D7E0DE-2035-40AE-A740-8F45A358A8F4 Login
  1. Home
  2. Mandates
  3. Vinge has advised Bilprovningen in connection with the disposal of Besiktningskluster 2 AB and a restructuring of the ownership in Bilprovningen
Mandate

Vinge has advised Bilprovningen in connection with the disposal of Besiktningskluster 2 AB and a restructuring of the ownership in Bilprovningen

January 25, 2013

Vinge has advised Aktiebolaget Svensk Bilprovning in connection with the restructuring of the ownership in Bilprovningen and the disposal of Besiktningskluster 2 AB to a consortium comprising the twelve minority shareholders in Bilprovningen. Besiktningskluster 2 AB owns around 1/3 of Bilprovningen’s network of inspection stations with a geographic focus in the south-west of Sweden. The restructuring of the ownership in Bilprovningen will result in the Swedish State becoming the sole owner of Bilprovningen. The disposal and restructuring is part of the reregulation and competition exposure of the Swedish vehicle inspection market. The transaction is subject to, inter alia, accreditation approval.

The Vinge team was led by Carl Gustaf De Geer, Daniel Rosvall and Peter Sundgren and included lawyers from a number of practice areas such as M&A, EU &Antitrust, IT, Employment & Benefits, Real Estate, Intellectual Property and also entailed regulatory issues regarding the motor vehicle inspection legislation.

Related

Vinge has advised Egetis Therapeutics in connection with a directed share issue

 Vinge has advised Egetis Therapeutics AB (publ) (“Egetis Therapeutics”), listed on Nasdaq Stockholm, in connection with a directed share issue whereby Egetis Therapeutics raised proceeds of approximately SEK 183 million before transaction costs.
October 06, 2025

Vinge worked with funds advised by Agilitas on the buy-out of Vivicta (previously Tietoevry Tech Services), including on the issuance of senior secured bonds and on entering into a super senior RCF

 Vinge, together with O’Melveny as lead counsel and Avance, worked with funds advised by Agilitas Private Equity LLP (“Agilitas”), the pan-European mid-market private equity firm, in their backing of Vivicta. The buy-out was previously announced on 24 March 2025 and closed on 2 September 2025.
October 03, 2025

Vinge has advised Hansa Biopharma in connection with a directed share issue of approx. SEK 671.5 million

 Vinge has advised Hansa Biopharma AB (publ) in connection with a directed share issue through which the company raises proceeds of approx. SEK 671.5 million before transaction costs.
October 03, 2025